Lebtahi R - Search Results

1

Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art.

de Mestier L, Dromain C, d'Assignies G, Scoazec JY, Lassau N, Lebtahi R, Brixi H, Mitry E, Guimbaud R, Courbon F, d'Herbomez M, Cadiot G. de Mestier L, et al. Among authors: lebtahi r. Endocr Relat Cancer. 2014 Apr 28;21(3):R105-20. doi: 10.1530/ERC-13-0365. Print 2014 Jun. Endocr Relat Cancer. 2014. PMID: 24351682 Review.

2

Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.

de Kerviler E, Cadiot G, Lebtahi R, Faraggi M, Le Guludec D, Mignon M. de Kerviler E, et al. Among authors: lebtahi r. Eur J Nucl Med. 1994 Nov;21(11):1191-7. doi: 10.1007/BF00182352. Eur J Nucl Med. 1994. PMID: 7859770

3

Left ventricular myocardial uptake of a labeled somatostatin analog in carcinoid syndrome.

Mure A, Lebtahi R, Sarda L, Glikmanas M, Cadiot G, Brochet E, Faraggi M, Le Guludec D. Mure A, et al. Among authors: lebtahi r. J Nucl Med. 1996 Feb;37(2):275-8. J Nucl Med. 1996. PMID: 8667061 Free article.

4

[Detection of endocrine tumors of the digestive tract. Value and limitations of scintigraphy of somatostatin receptors].

Le Guludec D, Cadiot G, Lebtahi R, Mignon M. Le Guludec D, et al. Among authors: lebtahi r. Presse Med. 1996 Apr 20;25(14):677-82. Presse Med. 1996. PMID: 8685125 Review. French.

5

Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.

Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y, Mignon M, le Guludec D. Lebtahi R, et al. J Nucl Med. 1997 Jun;38(6):853-8. J Nucl Med. 1997. PMID: 9189129 Free article.

6

False-positive somatostatin receptor scintigraphy due to an accessory spleen.

Lebtahi R, Cadiot G, Marmuse JP, Vissuzaine C, Petegnief Y, Courillon-Mallet A, Cattan D, Mignon M, Le Guludec D. Lebtahi R, et al. J Nucl Med. 1997 Dec;38(12):1979-81. J Nucl Med. 1997. PMID: 9430481 Free article.

7

Somatostatin receptor scintigraphy: a first-line imaging modality for gastroenteropancreatic neuroendocrine tumors.

Lebtahi R, Cadiot G, Mignon M, Le Guludec D. Lebtahi R, et al. Gastroenterology. 1998 Oct;115(4):1025-7. Gastroenterology. 1998. PMID: 9786730 No abstract available.

8

Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.

Lebtahi R, Cadiot G, Delahaye N, Genin R, Daou D, Peker MC, Chosidow D, Faraggi M, Mignon M, Le Guludec D. Lebtahi R, et al. J Nucl Med. 1999 Oct;40(10):1602-8. J Nucl Med. 1999. PMID: 10520698 Free article. Clinical Trial.

9

Imaging appearances of metastases from neuroendocrine tumours of the pancreas.

Debray MP, Geoffroy O, Laissy JP, Lebtahi R, Silbermann-Hoffman O, Henry-Feugeas MC, Cadiot G, Mignon M, Schouman-Claeys E. Debray MP, et al. Among authors: lebtahi r. Br J Radiol. 2001 Nov;74(887):1065-70. doi: 10.1259/bjr.74.887.741065. Br J Radiol. 2001. PMID: 11709476

10

Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.

Scigliano S, Lebtahi R, Maire F, Stievenart JL, Kianmanesh R, Sauvanet A, Vullierme MP, Couvelard A, Belghiti J, Ruszniewski P, Le Guludec D. Scigliano S, et al. Among authors: lebtahi r. Endocr Relat Cancer. 2009 Sep;16(3):977-90. doi: 10.1677/ERC-08-0247. Epub 2009 May 26. Endocr Relat Cancer. 2009. PMID: 19470616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters